Critical Community Psychology at Charles Sturt University
I am delighted to invite you to attend a presentation by community critical psychologist Paul Duckett (England) 23rd July from 3pm to 4.30 pm Centre for Professional Development (James Hardie Room) Charles Sturt University (Bathurst Campus) Paxil: A story about Politicians, Pharmacological Corporations, Academics and other corrupt bastards.
I will describe the work of the Seroxat and SSRI User Group in the UK. This group is fighting a multinational pharmaceutical corporation - GlaxoSmithKline (GSK) - the UK government, regulatory agencies and the medical and allied professions to secure social justice and social support for people harmed by the psycho-pharmaceutical industry. GSK manufactures and markets the drug Paroxetine - a Selective Serotonin Reuptake Inhibitor (SSRI) used in the treatment of, inter alia, 'depression' and 'anxiety disorders'. The drug is marketed under the brand names 'Seroxat' in the UK and 'Paxil' in Australia and the USA. In 2003, GSK were found to have withheld clinical trial data on Paroxetine that showed the drug was clinically ineffective and increased the risk of suicide in children and adolescents. GSK had, for at least five years, withheld the trial data for commercial reasons - to reduce any negative impact upon sales. In the UK GSK has survived attempts to criminally prosecute it, protected by the UK government's impotence, the UK regulatory body's incompetence and the academic community's improbity. There is now considerable evidence to suggest that Paroxetine is clinically ineffective and potentially toxic for adults as well as children. In spite of this, Paroxetine remains one of the world's best selling prescription drugs generating over 1 billion Australian Dollars for GSK in 2008, and children are still being prescribed the drug (e.g., in Australia during 2008, 4000 children under 10years of age were prescribed Paxil and other SSRI medications). I will describe how the UK political system, the medical profession, and the university sector have colluded with the pharmaceutical industry to promote GSK shareholder profits at the expense of public health and explain why Paxil is prescribed by our physicians rather than proscribed by our politicians. Paul Duckett is a community critical psychologist currently based in the Department of Psychology and Social Change at Manchester Metropolitan University, England, where he teaches community psychology and critical psychology. Paul is visiting community critical psychologists at Charles Sturt University after presenting as Keynote Speaker at the 11th Trans Tasman Community Psychology Conference in Fremantle Western Australia and lecturing in Hong Kong, Nanjing and Tokyo. Paul works in the fields of disability, mental health and unemployment. Since 1992 he has worked alongside disabled people including people who have a diagnosis of 'mental illness' and people who have been given the label of 'learning difficulty' (also known as 'intellectual impairment'). From 1998 onwards he has focused more on mental health issues and in 2006 became focused on the influence of the psycho-pharmaceutical corporate sector on the construction and treatment of 'mental illness' and the social harm such corporations can create. More generally, Paul's work has focused on understanding the violence of state and corporate crimes and to consider the culpability of consumer capitalist social systems(where profit is put before social ethics), and bureaucracies, where the moralisation of technology (doing a good job) transplants the morality of social action (doing for the greater good). Paul seeks to understand how capitalism and bureaucracies grow violence within and between communities and within and between nation states.
Arch Iranian Med 2005; 9 (2): 173 – 174 HOW TO MANAGE ASYMPTOMATIC LIVER HYDATIDS stage of the parasite Echinococcus granulosus in man.2 Mebendazole has been used for many years C countries. Only rarely now, and in India as an effective vermifuge with low primarily because of increased international travel, liver hydatids surface as clinical curiosities at accumulated to show that
What is dementia with Lewy bodies (DLB)? Dementia with Lewy bodies (DLB) is a form of dementia that shares characteristics with bothAlzheimer's and Parkinson's diseases. It accounts for around ten per cent of all cases of dementia inolder people and tends to be under-diagnosed. Dementia with Lewy bodies is sometimes referred toLewy body disease, cortical Lewy body disease and senile dem